Literature DB >> 8589136

Invasive colitis and hepatitis due to previously uncharacterized spirochetes in patients with advanced human immunodeficiency virus infection.

J R Kostman1, M Patel, E Catalano, J Camacho, J Hoffpauir, M J DiNubile.   

Abstract

We describe three patients with advanced human immunodeficiency virus (HIV) infection, two with colitis and one with cholestatic hepatitis, for whom results of detailed endoscopic and histologic studies were suggestive of invasive spirochetosis. In the two patients with colitis, colonoscopic evaluation revealed either diffuse ulcerations or pustules; in both cases, there was histologic evidence of extensive superficial cell necrosis and infiltration of the mucosa and lamina propria with acute inflammatory cells. Spirochetes in the mucosa and crypts were visualized by Warthin-Starry silver staining. Morphologically similar spirochetes throughout the liver specimen from the patient with cholestatic hepatitis were demonstrated by Warthin-Starry silver staining. Analysis with electron microscopy revealed these organisms to be loosely coiled spirochetes. Despite extensive evaluation, no other pathogens were identified. Invasive spirochetal infection, as defined by the results of Warthin-Starry silver staining of involved tissues, should be considered in the differential diagnosis of patients with HIV infection who have otherwise unexplained colitis or cholestatic hepatitis.

Entities:  

Mesh:

Year:  1995        PMID: 8589136     DOI: 10.1093/clinids/21.5.1159

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

Review 1.  The Spirochete Brachyspira pilosicoli, Enteric Pathogen of Animals and Humans.

Authors:  David J Hampson
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  Human intestinal spirochetosis in an immunocompromised host: evaluation of eradication therapy by endoscopy, histopathology and bacteriology.

Authors:  Takahito Takezawa; Shunji Hayashi; Yoshikazu Adachi; Keijiro Sunada; Yoshikazu Hayashi; Naoyuki Nishimura; Tomonori Yano; Tomohiko Miyata; Hironori Yamamoto; Yoshikazu Hirai; Kentaro Sugano
Journal:  Clin J Gastroenterol       Date:  2011-11-27

3.  Symptomatic colonic spirochaetosis in an immunocompetent patient.

Authors:  R K Lin; K Miyai; J M Carethers
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

4.  PCR amplification from fixed tissue indicates frequent involvement of Brachyspira aalborgi in human intestinal spirochetosis.

Authors:  A S Mikosza; T La; C J Brooke; C F Lindboe; P B Ward; R G Heine; J G Guccion; W B de Boer; D J Hampson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  Isolation of Serpulina pilosicoli from rectal biopsy specimens showing evidence of intestinal spirochetosis.

Authors:  N L Trivett-Moore; G L Gilbert; C L Law; D J Trott; D J Hampson
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Identification and characterization of Serpulina pilosicoli isolates recovered from the blood of critically ill patients.

Authors:  D J Trott; N S Jensen; I Saint Girons; S L Oxberry; T B Stanton; D Lindquist; D J Hampson
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

7.  Brachyspira aalborgi infection diagnosed by culture and 16S ribosomal DNA sequencing using human colonic biopsy specimens.

Authors:  W Kraaz; B Pettersson; U Thunberg; L Engstrand; C Fellström
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 8.  [Human intestinal spirochetosis].

Authors:  B Knopf; B Bethke; M Stolte
Journal:  Pathologe       Date:  2003-04-03       Impact factor: 1.011

Review 9.  Human intestinal spirochetosis--a review.

Authors:  Efstathia Tsinganou; Jan-Olaf Gebbers
Journal:  Ger Med Sci       Date:  2010-01-07

10.  In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.

Authors:  C J Brooke; D J Hampson; T V Riley
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.